» Articles » PMID: 26024084

Lipotoxicity Augments Glucotoxicity-induced Mitochondrial Damage in the Development of Diabetic Retinopathy

Overview
Specialty Ophthalmology
Date 2015 May 30
PMID 26024084
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Although hyperglycemia is the main instigator in the development of diabetic retinopathy, dyslipidemia is also considered to play an important role. In the pathogenesis of diabetic retinopathy, cytosolic NADPH oxidase 2 (Nox2) is activated before retinal mitochondria are damaged. Our aim was to investigate the effect of lipids in the development of diabetic retinopathy.

Methods: Reactive oxygen species (ROS, by 2',7'-dichlorofluorescein diacetate) and activities of Nox2 (by a lucigenin-based method) and Rac1 (by G-LISA) were quantified in retinal endothelial cells incubated with 50 μM palmitate in 5 mM glucose (lipotoxicity) or 20 mM glucose (glucolipotoxicity) for 6 to 96 hours. Mitochondrial DNA (mtDNA) damage was evaluated by extended-length PCR and its transcription by quantifying cytochrome b transcripts.

Results: Within 6 hours of exposure of endothelial cells to lipotoxicity, or glucotoxicity (20 mM glucose, without palmitate), significant increase in ROS, Nox2, and Rac1 was observed, which was exacerbated by glucolipotoxic insult. At 48 hours, neither lipotoxicity nor glucotoxicity had any effect on mtDNA and its transcription, but glucolipotoxicity significantly damaged mtDNA and decreased cytochrome b transcripts, and at 96 hours, glucotoxicity and glucolipotoxicity produced similar detrimental effects on mitochondrial damage.

Conclusions: Although during initial exposure, lipotoxic or glucotoxic insult produces similar increase in ROS, addition of lipotoxicity in a glucotoxic environment further exacerbates ROS production, and also accelerates their damaging effects on mitochondrial homeostasis. Thus, modulation of Nox2 by pharmacological agents in prediabetic patients with dyslipidemia could retard the development of retinopathy before their hyperglycemia is observable.

Citing Articles

Horizontal mitochondrial transfer as a novel bioenergetic tool for mesenchymal stromal/stem cells: molecular mechanisms and therapeutic potential in a variety of diseases.

Iorio R, Petricca S, Mattei V, Delle Monache S J Transl Med. 2024; 22(1):491.

PMID: 38790026 PMC: 11127344. DOI: 10.1186/s12967-024-05047-4.


Protective effect of chitosan-modified rice porous starch loaded catechin on HT-29 cells exposed to lead ion.

Jiang S, Hu H Heliyon. 2024; 10(2):e25019.

PMID: 38312581 PMC: 10835365. DOI: 10.1016/j.heliyon.2024.e25019.


Untargeted and temporal analysis of retinal lipidome in bacterial endophthalmitis.

Ahmad Z, Singh S, Lee T, Sharma A, Lydic T, Giri S Prostaglandins Other Lipid Mediat. 2024; 171:106806.

PMID: 38185280 PMC: 10939753. DOI: 10.1016/j.prostaglandins.2023.106806.


SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy.

Wang Y, Liu T, Cai Y, Liu W, Guo J Front Endocrinol (Lausanne). 2023; 14:1244705.

PMID: 37876546 PMC: 10591331. DOI: 10.3389/fendo.2023.1244705.


lncRNA HOTAIR promotes ROS generation and NLRP3 inflammasome activation by inhibiting Nrf2 in diabetic retinopathy.

You H, Li H, Gou W Medicine (Baltimore). 2023; 102(37):e35155.

PMID: 37713847 PMC: 10508377. DOI: 10.1097/MD.0000000000035155.


References
1.
Chew E, Davis M, Danis R, Lovato J, Perdue L, Greven C . The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 2014; 121(12):2443-51. PMC: 4252767. DOI: 10.1016/j.ophtha.2014.07.019. View

2.
Fu D, Yu J, Wu M, Du M, Chen Y, Abdelsamie S . Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes. J Lipid Res. 2014; 55(5):860-9. PMC: 3995464. DOI: 10.1194/jlr.M045401. View

3.
Ibrahim A, Elshafey S, Sellak H, Hussein K, El-Sherbiny M, Abdelsaid M . A lipidomic screen of hyperglycemia-treated HRECs links 12/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase. J Lipid Res. 2015; 56(3):599-611. PMC: 4340307. DOI: 10.1194/jlr.M056069. View

4.
Klein B, Myers C, Howard K, Klein R . Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. JAMA Ophthalmol. 2014; 133(5):503-10. PMC: 4433425. DOI: 10.1001/jamaophthalmol.2014.5108. View

5.
Kern T, Tang J, Mizutani M, Kowluru R, Nagaraj R, Romeo G . Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci. 2000; 41(12):3972-8. View